Biological approaches to aphasia treatment

Current Neurology and Neuroscience Reports

Volumn 9, Issue 6, 2009, Pages 443-450

  Small, Steven L ^a   Llano, Daniel A ^b  

^a UNIVERSITY OF CHICAGO   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCHOLINE; BRAIN DERIVED NEUROTROPHIC FACTOR; BROMOCRIPTINE; CATECHOLAMINE; DESMOPRESSIN; DEXAMPHETAMINE; DONEPEZIL; LEVODOPA; MEMANTINE; NOGO A ANTIBODY; PIRACETAM; PLACEBO; SEROTONIN; TRICYCLIC ANTIDEPRESSANT AGENT;

APHASIA; CELL TRANSPLANTATION; CEREBROVASCULAR ACCIDENT; CHOLINERGIC ACTIVITY; CLINICAL TRIAL; DEPRESSION; DRUG CONTRAINDICATION; DRUG EFFICACY; DRUG MEGADOSE; EXTRACELLULAR MATRIX; GABAERGIC SYSTEM; HUMAN; NEUROPROTECTION; NONHUMAN; REVIEW; SPEECH THERAPY; TRANSCRANIAL MAGNETIC STIMULATION;

ACETYLCHOLINE; ANIMALS; APHASIA; CATECHOLAMINES; DISEASE MODELS, ANIMAL; EXTRACELLULAR MATRIX; HUMANS; RECOVERY OF FUNCTION; STROKE; TISSUE THERAPY;

EID: 70350169896     PISSN: 15284042     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11910-009-0066-x     Document Type: Review

References (76)

1. Small SL: Biological approaches to the treatment of aphasia. In Handbook on Adult Language Disorders: Integrating Cognitive Neuropsychology, Neurology, and Rehabilitation. Edited by Hillis A. Philadelphia: Psychology Press; 2001:397-411.
2. Horng S, Sur M: Visual activity and cortical rewiring: activity-dependent plasticity of cortical networks. Prog Brain Res 2006, 157:3-11.
3. McCloskey M, Cohen NJ: Catastrophic interference in connectionist networks: The sequential learning problem. In The Psychology of Learning and Motivation. Edited by Bower G. New York: Academic Press; 1989:109-165.
4. Gernsbacher MA, St. JoPn MF: Learning and losing syntax: practice makes perfect and frequency builds fortitude. In Foreign Language Learning: Psycholinguistic Experiments on Training and Retention. Edited by Healy AF, Bourne JLE. Mawah, NJ: Laurence Erlbaum Associates; 1998:231-255.
5. Cohen HP, Woltz AG, Jacobson RL: Catecholamine content of cerebral tissue after occlusion or manipulation of middle cerebral artery in cats. J Neurosurg 1975, 43:32-36.
6. Feeney D, Westerberg V: NorApinephrine and brain damage: alpha noradrenergic pharmacology alters functional recovery after cortical trauma. Can J Psychol 1990, 44:233-252.
7. Stroemer RP, Kent TA, Hulsebosch CE: Neocortical neural sprouting, synaptogenesis, and behavioral recovery after neocortical infarction in rats. Stroke 1995, 26:2135-2144.
8. Hiramoto T, Ihara Y, Watanabe Y: Alpha-1 Adrenergic receptors stimulation induces the proliferation of neural progenitor cells in vitro. Neurosci Lett 2006, 408:25-28.
9. Izumi Y, Zorumski C: Norepinephrine promotes long-term potentiation in the adult rat hippocampus in vitro. Synapse 1999, 31:196-202.
10. Feeney D, Gonzalez A, Law W: Amphetamine, haloperidol, and experience interact to affect rate of recovery after motor cortex injury. Science 1982, 217:855-857.
11. Papadopoulos CM, Tsai SY, Guillen V, et al.: Motor recovery and axonal plasticity with short-term amphetamine after stroke. Stroke 2009, 40:294-302.
12. Ramic M, Emerick AJ, Bollnow MR, et al.: Axonal plasticity is associated with motor recovery following amphetamine treatment combined with rehabilitation after brain injury in the adult rat. Brain Res 2006, 1111:176-186.
13. Boyeson MG, Feeney DM: The role of norepinephrine in recovery from brain injury [abstract]. Presented at the Annual Meeting of the Society for Neuroscience. Anaheim, CA; October 10-15, 1984.
14. Breitenstein C, Flöel A, Korsukewitz C, et al.: A shift of paradigm: From noradrenergic to dopaminergic modulation of learning? J Neurol Sci 2006, 248:42-47.
15. Kilgard MP, Merzenich MM: Cortical map reorganization enabled by nucleus basalis activity. Science 1998, 279:1714-1718.
16. Thiel CM, Friston KJ, Dolan RJ: Cholinergic modulation of experience-dependent plasticity in human auditory cortex. Neuron 2002, 35:567-574.
17. Gu Q, Singer W: Involvement of serotonin in developmental plasticity of kitten visual cortex. Eur J Neurosci 1995, 7:1146-1153.
18. Li WL, Cai HH, Wang B, et al.: Chronic fluoxetine treatment improves ischemia-induced spatial cognitive deficits through increasing hippocampal neurogenesis after stroke. J Neurosci Res 2009, 87:112-122.
19. Ploughman M, Windle V, MacLellan CL, et al.: Brainderived neurotrophic factor contributes to recovery of skilled reaching after focal ischemia in rats. Stroke 2009, 40:1490-1495.
20. Schabitz WR, Steigleder T, Cooper-Kuhn CM, et al.: Intravenous brain-derived neurotrophic factor enhances poststroke sensorimotor recovery and stimulates neurogenesis. Stroke 2007, 38:2165-2172.
21. Boyeson M, Harmon R, Jones J: Comparative effects of fluoxetine, amitriptyline and serotonin on functional motor recovery after sensorimotor cortex injury. Am J Phys Med Rehabil 1994, 73:76-83.
22. Windle V, Corbett D: Fluoxetine and recovery of motor function after focal ischemia in rats. Brain Res 2005, 1044:25-32.
23. Tsai S, Markus S, Andrews EM, et al.: Intrathecal treatment with anti-Nogo-A antibody improves functional recovery in adult rats after stroke. Exp Brain Res 2007, 182:261-266.
24. Brenneman MM, Wagner SJ, Cheatwood JL, et al.: Nogo-A inhibition induces recovery from neglect in rats. Behav Brain Res 2008, 187:262-272.
25. Kondziolka D, Wechsler L, Goldstein S, et al.: Transplantation of cultured human neuronal cells for patients with stroke. Neurology 2000, 55:565-569.
26. Bang O, Lee J, Lee P, et al.: Autologous mesenchymal stem cell transplantation in stroke patients. Ann Neurol 2005, 57:874-882.
27. Savitz SI, Dinsmore J, Wu J, et al.: Neurotransplantation of fetal porcine cells in patients with basal ganglia infarcts: A preliminary safety and feasibility study. Cerebrovasc Dis 2005, 20:101-107.
28. Sprigg N, Bath PM, Zhao L, et al.: Granulocyte-colonystimulating factor mobilizes bone marrow stem cells in patients with subacute ischemic stroke: The Stem cell Trial of recovery EnhanceMent after Stroke (STEMS) pilot randomized, controlled trial (ISRCTN 16784092). Stroke 2006, 37:2979-2983.
29. Liu YP, Seckin H, Izci Y, et al.: Neuroprotective effects of mesenchymal stem cells derived from human embryonic stem cells in transient focal cerebral ischemia in rats. J Cereb Blood Flow Metab 2009, 29:780-791.
30. Shyu WC, Lin SZ, Chiang MF, et al.: Intracerebral peripheral blood stem cell (CD34+) implantation induces neuroplasticity by enhancing beta1 integrin-mediated angiogenesis in chronic stroke rats. J Neurosci 2006, 26:3444-3453.
31. Hicks AU, Hewlett K, Windle V, et al.: Enriched environment enhances transplanted subventricular zone stem cell migration and functional recovery after stroke. Neuroscience 2007, 146:31-40.
32. Walker-Batson D, Curtis S, Natarajan R, et al.: A doubleblind, placebo-controlled study of the use of amphetamine in the treatment of aphasia [editorial comment]. Stroke 2001, 32:2093-2098.
33. Whiting E, Chenery HJ, Chalk J, et al.: Dexamphetamine boosts naming treatment effects in chronic aphasia. J Int Neuropsychol Soc 2007, 13:972-979.
34. Darley F, Keith R, Sasanuma S: The effect of alerting and tranquilizing drugs upon the performance of aphasic patients. Clin Aphasiol 1977, 7:91-96.
35. McNeil MR, Doyle PJ, Spencer KA, et al.: A double-blind, placebo-controlled study of pharmacological and behavioral treatment of lexical-semantic deficits in aphasia. Aphasiology 1997, 11:358-400.
36. Breitenstein C, Wailke S, Bushuven S, et al.: D-amphetamine boosts language learning independent of its cardiovascular and motor arousing effects. Neuropsychopharmacology 2004, 29:1704-1714.
37. Uftring S, Wachtel S, Chu D, et al.: An fMRI study of the effect of amphetamine on brain activity. Neuropsychopharmacology 2001, 25:925-935.
38. Sommer I, Oranje B, Ramsey N, et al.: The influence of amphetamine on language activation: An fMRI study. Psychopharmacology 2006, 183:387-393.
39. Gladstone DJ, Danells CJ, Armesto A, et al.: Physiotherapy coupled with dextroamphetamine for rehabilitation after hemiparetic stroke: A randomized, double-blind, placebo-controlled trial. Stroke 2006, 37:179-185.
40. Platz T, Kim IH, Engel U, et al.: Amphetamine fails to facilitate motor performance and to enhance motor recovery among stroke patients with mild arm paresis: Interim analysis and termination of a double blind, randomised, placebo-controlled trial. Restor Neurol Neurosci 2005, 23:271-280.
41. Beversdorf DQ, Sharma UK, Phillips NN, et al.: Effect of propranolol on naming in chronic Broca's aphasia with anomia. Neurocase 2007, 13:256-259.
42. Bragoni M, Altieri M, Di Piero V, et al.: Bromocriptine and speech therapy in non-fluent chronic aphasia after stroke. Neurol Sci 2000, 21:19-22.
43. Seniów J, Litwin M, Litwin T, et al.: New approach to the rehabilitation of post-stroke focal cognitive syndrome: Effect of levodopa combined with speech and language therapy on functional recovery from aphasia. J Neurol Sci 2009, 283:214-218.
44. Ashtary F, Janghorbani M, Chitsaz A, et al.: A randomized, double-blind trial of bromocriptine efficacy in nonfluent aphasia after stroke. Neurology 2006, 66:914-916.
45. Sabe L, Salvarezza F, García Cuerva A, et al.: A randomized, double-blind, placebo-controlled study of bromocriptine in nonfluent aphasia. Neurology 1995, 45:2272-2274.
46. Gupta S, Mlcoch A, Scolaro C, et al.: Bromocriptine treatment of nonfluent aphasia. Neurology 1995, 45:2170-2173.
47. Rösser N, Heuschmann P, Wersching H, et al.: Levodopa improves procedural motor learning in chronic stroke patients. Arch Phys Med Rehabil 2008, 89:1633-1641.
48. Scheidtmann K, Fries W, Muller F, Koenig E: Effect of levodopa in combination with physiotherapy on functional motor recovery after stroke: A prospective, randomised, double-blind study. Lancet 2001, 358:787-790.
49. Berthier ML, Green C, Higueras C, et al.: A randomized, placebo-controlled study of donepezil in poststroke aphasia. Neurology 2006, 67:1687-1689.
50. Müller W, Eckert G, Eckert A: Piracetam: novelty in a unique mode of action. Pharmacopsychiatry 1999, 32:2-9.
51. Enderby P, Broeckx J, Hospers W, et al.: Effect of piracetam on recovery and rehabilitation after stroke: A double-blind, placebo-controlled study. Clin Neuropharmacol 1994, 17:320-331.
52. Huber W, Willmes K, Poeck K, et al.: Piracetam as an adjuvant to language therapy for aphasia: A randomized double-blind placebo-controlled pilot study. Arch Phys Med Rehabil 1997, 78:245-250.
53. Kessler J, Thiel A, Karbe H, et al.: Piracetam improves activated blood flow and facilitates rehabilitation of poststroke aphasic patients. Stroke 2000, 31:2112-2116.
54. Berthier M, Green C, Lara J, et al.: Memantine and constraint-induced aphasia therapy in chronic poststroke aphasia. Ann Neurol 2009, 65:577-585.
55. Pulvermüller F, Neininger B, Elbert T, et al.: Constraintinduced therapy of chronic aphasia after stroke. Stroke 2001, 32:1621-1626.
56. Donaldson Z, Young L: Oxytocin, vasopressin, and the neurogenetics of sociality. Science 2008, 322:900-904.
57. Tsikunov SG, Belokoskova SG: Psychophysiological analysis of the influence of vasopressin on speech in patients with post-stroke aphasias. Span J Psychol 2007, 10:178-188.
58. Devlin JT, WatkiIs KE: Stimulating language: insights from TMS. Brain 2007, 130:610-622.
59. Cotelli M, Manenti R, Cappa SF, et al.: Transcranial magnetic stimulation improves naming in Alzheimer disease patients at different stages of cognitive decline. Eur J Neurol 2008, 15:1286-1292.
60. Naeser MA, Martin PI, Nicholas M, et al.: Improved picture naming in chronic aphasia after TMS to part of right Broca's area: An open-protocol study. Brain Lang 2005, 93:95-105.
61. Floel A, Rosser N, Michka O, et al.: Noninvasive brain stimulation improves language learning. J Cogn Neurosci 2008, 20:1415-1422.
62. Hesse S, Werner C, Schonhardt EM, et al.: Combined transcranial direct current stimulation and robot-assisted arm training in subacute stroke patients: A pilot study. Restor Neurol Neurosci 2007, 25:9-15.
63. Gil R, Neau JP: Rapid aggravation of aphasia by vigabatrin. J Neurol 1995, 242:251-252.
64. Kennedy G, Lhatoo S: CNS adverse events associated with antiepileptic drugs. CNS Drugs 2008, 22:739-760.
65. Mula M, Trimble MR, Thrompson P, et al.: Topiramate and word-finding difficulties in patients with epilepsy. Neurology 2003, 60:1104-1107.
66. Starkstein SE, Robinson RG: Affective disorders and cerebral vascular disease. Br J Psychiatry 1989, 154:170-182.
67. van de Weg F, Kuik D, Lankhorst G: Post-stroke depression and functional outcome: A cohort study investigating the influence of depression on functional recovery from stroke. Clin Rehabil 1999, 13:268-272.
68. Robinson RG: The Clinical Neuropsychiatry of Stroke: Cognitive, Behavioral and Emotional Disorders Following Vascular Brain Injury. Cambridge, UK: Cambridge University Press; 1998.
69. Task Force on DSM-IV: Diagnostic and Statistical Manual of Mental Disorders: Fourth Edition (Text Revision). Washington, DC: American Psychiatric Association; 1994:943.
70. Laska AC, Märtensson B, Kahan T, et al.: Recognition of depression in aphasic stroke patients. Cerebrovasc Dis 2007, 24:74-79.
71. Hilari K, Byng S: Health-related quality of life in people with severe aphasia. Int J Lang Commun Disord 2009, 44:193-205.
72. Lipsey JR, Robinson RG, Pearlson GD, et al.: Nortriptyline treatment of post-stroke depression: A double-blind study. Lancet 1984, 1:297-300.
73. Andersen G, Vestergaard K, Lauritzen L: Effective treatment of poststroke depression with the selective serotonin reuptake inhibitor citalopram. Stroke 1994, 25:1099-1104.
74. Rampello L, Chiechio S, Nicoletti G, et al.: Prediction of the response to citalopram and reboxetine in post-stroke depressed patients. Psychopharmacology (Berl) 2004, 173:73-78.
75. Robinson RG, Jorge RE, Moser DJ, et al.: Escitalopram and problem-solving therapy for prevention of poststroke depression: A randomized controlled trial. JAMA 2008, 299:2391-2400.
76. Nadeau S, Wu S: CIMT as a behavioral engine in research on physiological adjuvants to neurorehabilitation: The challenge of merging animal and human research. Neurorehabilitation 2006, 21:107-130.